{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:14:05Z","timestamp":1786976045702,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd011188.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000}}],"reference-count":82,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011188.pub3","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T12:53:06Z","timestamp":1653655986000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Corticosteroids for the treatment of Kawasaki disease in children"],"prefix":"10.1002","volume":"2022","author":[{"given":"Jessica","family":"Green","sequence":"additional","affiliation":[{"name":"Children's & Adolescent Services; Whiston Hospital, St Helens and Knowsley Teaching Hospitals NHS Trust; Prescot, Merseyside UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Wardle","sequence":"additional","affiliation":[{"name":"Cardiology, Hammersmith Hospital; Imperial College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert MR","family":"Tulloh","sequence":"additional","affiliation":[{"name":"Congenital Heart Disease; Bristol Royal Hospital for Children and Bristol Heart Institute; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"issue":"Suppl 1","key":"10.1002\/14651858.CD011188.pub3-BIB0001|cit1","first-page":"38","article-title":"Risk stratification and effectiveness of intravenous immunoglobulin plus prednisolone as the initial treatment of Kawasaki disease","volume":"165","author":"Ikeda","year":"2006","journal-title":"European Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD011188.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jpeds.2006.05.025","article-title":"A multicentre prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome","volume":"149","author":"Inoue","year":"2006","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0003|cit3","first-page":"S144","article-title":"Optimal timing of initial treatment in severe Kawasaki disease: a sub-analysis of the RAISE study","volume":"23","author":"Ikeda","year":"2013","journal-title":"Cardiology in the Young"},{"issue":"21","key":"10.1002\/14651858.CD011188.pub3-BIB0004|cit4","article-title":"The efficacy and safety of new strategy for refractory Kawasaki disease","volume":"18","author":"Ishii","year":"2011","journal-title":"Cardiology in the Young"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0005|cit5","unstructured":"Randomized controlled trial to assess immunoglobulin plus steroid efficacy for Kawasaki disease (protocol) apps.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000000940"},{"issue":"9826","key":"10.1002\/14651858.CD011188.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011188.pub3-BIB0007|cit7","first-page":"53","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease","volume":"54","author":"Kobayashi","year":"2012","journal-title":"Pediatrics International"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"A9271","DOI":"10.1161\/circ.124.suppl_21.A9271","article-title":"Significance of primary therapy with intravenous immunoglobulin plus prednisolone for severe Kawasaki disease: result from Japanese multicenter randomized clinical trial","volume":"124","author":"Kobayashi","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD011188.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIRCULATIONAHA.107.690875","article-title":"Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements","volume":"116","author":"McCrindle","year":"2007","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0010|cit10","unstructured":"Trial of pulse steroid therapy in Kawasaki Disease \u2013 Pediatric Heart Network clinicaltrials.gov\/show\/NCT00132080"},{"issue":"7","key":"10.1002\/14651858.CD011188.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMoa061235","article-title":"Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease","volume":"356","author":"Newburger","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011188.pub3-BIB0012|cit12","first-page":"104","article-title":"Clinical utility of a new strategy for preventing coronary artery lesions in refractory Kawasaki disease patients: a randomized prospective study","volume":"54","author":"Ishii","year":"2012","journal-title":"Pediatrics International"},{"issue":"1","key":"10.1002\/14651858.CD011188.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1542\/peds.2011-0148","article-title":"Cortocosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial","volume":"129","author":"Ogata","year":"2012","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD011188.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1067\/S0022-3476(03)00387-1","article-title":"Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children","volume":"143","author":"Okada","year":"2003","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD011188.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1067\/mpd.2003.191","article-title":"Corticosteroids in the initial treatment of Kawasaki disease: report of a randomised trial","volume":"142","author":"Sundel","year":"2003","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1203\/00006450-200301000-00063","article-title":"Randomized trial of pulse steroids in the initial treatment of Kawasaki disease (KD)","volume":"53","author":"Sundel","year":"2003","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"ID 4175821","DOI":"10.1155\/2020\/4175821","article-title":"Methylprednisolone pulse therapy or additional IVIG for patients with IVIG-resistant Kawasaki disease","volume":"2020","author":"Wang","year":"2020","journal-title":"Journal of Immunology Research"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0018|cit18","first-page":"995","article-title":"Follow up data of prospective controlled study for the treatment, clinical sign and laboratory data of Kawasaki disease","volume":"26","author":"Asai","year":"1985","journal-title":"Shonika. Pediatrics of Japan"},{"issue":"3","key":"10.1002\/14651858.CD011188.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1442-200x.2001.01373.x","article-title":"Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy","volume":"43","author":"Hashino","year":"2001","journal-title":"Pediatrics International"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0020|cit20","unstructured":"Multi-centre randomised placebo-controlled trial of corticosteroids in the prevention of coronary artery abnormalities in acute Kawasaki Disease (KD) www.isrctn.com\/ISRCTN74427627"},{"issue":"4-5","key":"10.1002\/14651858.CD011188.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00431-003-1386-5","article-title":"Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease","volume":"163","author":"Jibiki","year":"2004","journal-title":"European Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD011188.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1542\/peds.63.2.175","article-title":"Kawasaki disease: effect of treatment on coronary artery involvement","volume":"63","author":"Kato","year":"1979","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0023|cit23","first-page":"2465","article-title":"A prospective study for treatment of Kawasaki disease with 3 regimes: aspirin, flubiprofen, predonisolone + dipyridamole","volume":"87","author":"Kusakawa","year":"1983","journal-title":"Nippon Shonika Gakkai Zasshi"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0024|cit24","first-page":"1844","article-title":"A randomised controlled study of three different therapies for patients having Kawasaki disease","volume":"90","author":"Kusakawa","year":"1986","journal-title":"Nippon Shonika Gakkai Zasshi"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0025|cit25","first-page":"814","article-title":"Studies on the treatment of Kawasaki disease during acute stage","volume":"89","author":"Kusakawa","year":"1985","journal-title":"Nippon Shonika Gakkai Zasshi"},{"issue":"10","key":"10.1002\/14651858.CD011188.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00431-007-0642-5","article-title":"Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin","volume":"167","author":"Miura","year":"2008","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0027|cit27","first-page":"1845","article-title":"Studies on activated platelets in Kawasaki disease","volume":"89","author":"Nakamura","year":"1985","journal-title":"Nippon Shonika Gakkai Zasshi"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0028|cit28","first-page":"328","volume-title":"Kawasaki Disease","author":"Nonaka","year":"1995"},{"issue":"4","key":"10.1002\/14651858.CD011188.pub3-BIB0029|cit29","first-page":"565","article-title":"The combination therapy with gamma-globulin and prednisolone is an supportive or alternative for Kawasaki disease in high risk","volume":"47","author":"Nonaka","year":"2000","journal-title":"Pediatric Research"},{"issue":"5","key":"10.1002\/14651858.CD011188.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1203\/PDR.0b013e3181baa3c2","article-title":"Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone","volume":"66","author":"Ogata","year":"2009","journal-title":"Pediatric Research"},{"issue":"3","key":"10.1002\/14651858.CD011188.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s10753-011-9398-1","article-title":"Regulation of oxidative stress in patients with Kawasaki disease","volume":"35","author":"Sekine","year":"2012","journal-title":"Inflammation"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0032|cit32","first-page":"399","article-title":"A controlled trial of steroid pulse therapy for Kawasaki disease","volume":"87","author":"Seto","year":"1983","journal-title":"Nippon Shonika Gakkai Zasshi"},{"issue":"2","key":"10.1002\/14651858.CD011188.pub3-BIB0033|cit33","first-page":"432","article-title":"The addition of glucocorticoids to initial IVIG therapy in children with Kawasaki disease","volume":"29","author":"Shiari","year":"2011","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD011188.pub3-BIB0034|cit34","first-page":"680","article-title":"Observation of coronary artery diseases in Kawasaki diseases with methylprednisolone","volume":"17","author":"Xu","year":"2002","journal-title":"Journal of Applied Clinical Pediatrics"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0035|cit35","first-page":"49","article-title":"Analysis of recent effects for corticosteroid in treating Kawasaki disease","volume":"15","author":"Yuan","year":"2000","journal-title":"Chinese Journal of Practical Paediatrics"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0036|cit36","unstructured":"Clinical study of glucocorticoid combined with immunoglobulin in the treatment of Kawasaki disease trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR1800017994"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0037|cit37","unstructured":"Research on individualized treatment for intravenous immunoglobulin resistant children with Kawasaki disease trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR-IOR-16007862"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0038|cit38","unstructured":"A methylprednisolone-plus-intravenous immunoglobulin combination therapy for refractory Kawasaki disease trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-UMIN000005022"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0039|cit39","unstructured":"Prospective multicenter trial to assess the effectiveness and safety of pulse methylprednisolone combined with intravenous immunoglobulin (IVIG) as a primary treatment in patients with acute Kawasaki disease center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000011649"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0040|cit40","unstructured":"Kawasaki disease coronary artery aneurysm prevention trial www.clinicaltrialsregister.eu\/ctr-search\/trial\/2019-004433-17\/GB"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0041|cit41","unstructured":"Corticosteroids plus standard of care treatment versus standard of care treatment alone to prevent heart complications in Kawasaki disease trialsearch.who.int\/Trial2.aspx?TrialID=ISRCTN71987471"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0042|cit42","unstructured":"Evaluation of primary intravenous methyl prednisolone pulse treatment in the prevention of coronary artery abnormality in children with Kawasaki disease www.irct.ir\/trial\/35607"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0043|cit43","unstructured":"A prospective randomized controlled trial of immunoglobulin plus prednisolone for Kawasaki disease patients with high risk for coronary abnormalities trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-UMIN000009524"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0044|cit44","unstructured":"Addition of methylprednisolone to initial treatment for Kawasaki disease patients clinicaltrials.gov\/ProvidedDocs\/68\/NCT04078568\/Prot_000.pdf"},{"issue":"7454","key":"10.1002\/14651858.CD011188.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"GRADE Working Group. Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD011188.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1442-200x.2005.02033.x","article-title":"Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)","volume":"47","author":"Ayusawa","year":"2005","journal-title":"Pediatrics International"},{"issue":"4","key":"10.1002\/14651858.CD011188.pub3-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004175.pub2","article-title":"Salicylate for the treatment of Kawasaki disease in children","author":"Baumer","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011188.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/adc.86.4.286","article-title":"Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research","volume":"86","author":"Brogan","year":"2002","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1002\/14651858.CD011188.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0735-1097(96)00099-X","article-title":"Sequelae of Kawasaki disease in adolescents and young adults","volume":"28","author":"Burns","year":"1996","journal-title":"Journal of the American College of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD011188.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/jamapediatrics.2016.2055","article-title":"Coronary artery complication in Kawasaki disease and the importance of early intervention: a systematic review and meta-analysis","volume":"170","author":"Chen","year":"2016","journal-title":"JAMA Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD011188.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/HCO.0b013e3283588f06","article-title":"Kawasaki disease: late cardiovascular sequelae","volume":"27","author":"Daniels","year":"2012","journal-title":"Current Opinion in Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD011188.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s00246-013-0731-3","article-title":"Should infliximab be used as an adjuvant to IVIG in the treatment of children with Kawasaki disease who are at high risk for resistance to conventional therapy?","volume":"34","author":"Davies","year":"2013","journal-title":"Pediatric Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD011188.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0022-3476(98)70229-X","article-title":"Coronary artery dimensions may be misclassified as normal in Kawasaki disease","volume":"133","author":"Zorzi","year":"1998","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD011188.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/archdischild-2012-302841","article-title":"Management of Kawasaki disease","volume":"99","author":"Eleftheriou","year":"2013","journal-title":"Archives of Disease in Childhood"},{"issue":"9341","key":"10.1002\/14651858.CD011188.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Sch\u00f6nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin","year":"2002","journal-title":"Lancet"},{"issue":"7351","key":"10.1002\/14651858.CD011188.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1136\/bmj.324.7351.1424","article-title":"Rising incidence of Kawasaki disease in England: analysis of hospital admission data","volume":"324","author":"Harnden","year":"2002","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD011188.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1442-200x.2001.01373.x","article-title":"Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy","volume":"43","author":"Hashino","year":"2001","journal-title":"Pediatrics International"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0058|cit58","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"1","key":"10.1002\/14651858.CD011188.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1442-200X.2011.03487.x","article-title":"Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease","volume":"54","author":"Hokosaki","year":"2012","journal-title":"Pediatrics International"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD011188.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.112.3.495","article-title":"Kawasaki syndrome hospitalizations in the United States; 1997 and 2000","volume":"112","author":"Holman","year":"2003","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD011188.pub3-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003284.pub3","article-title":"Steroid hormone treatment for Kawasaki disease in children","author":"Jones","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD011188.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients","volume":"94","author":"Kato","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD011188.pub3-BIB0063|cit63","first-page":"178","article-title":"Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children","volume":"16","author":"Kawasaki","year":"1967","journal-title":"Arerugi"},{"issue":"4","key":"10.1002\/14651858.CD011188.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ped.13190","article-title":"Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease","volume":"59","author":"Kimura","year":"2017","journal-title":"Pediatrics International"},{"issue":"2","key":"10.1002\/14651858.CD011188.pub3-BIB0065|cit65","first-page":"332","article-title":"Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease","volume":"66","author":"Kobayashi","year":"2008","journal-title":"Japanese Journal of Clinical Medicine"},{"issue":"10","key":"10.1002\/14651858.CD011188.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/ped.14326","article-title":"Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)","volume":"62","author":"Kobayashi","year":"2020","journal-title":"Pediatrics International"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0067|cit67","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"12","key":"10.1002\/14651858.CD011188.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/adc.66.12.1369","article-title":"Kawasaki disease: recent advances","volume":"66","author":"Levin","year":"1991","journal-title":"Archives of Disease in Childhood"},{"issue":"2","key":"10.1002\/14651858.CD011188.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/heartjnl-2012-302407","article-title":"Steroids for Kawasaki disease: the devil is in the detail","volume":"99","author":"Levin","year":"2013","journal-title":"Heart"},{"issue":"17","key":"10.1002\/14651858.CD011188.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD011188.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2188\/jea.JE20110126","article-title":"Epidemiologic features of Kawasaki disease in Japan: results of the 2009\u20132010 nationwide survey","volume":"22","author":"Nakamura","year":"2012","journal-title":"Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD011188.pub3-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004000","article-title":"Intravenous immunoglobulin for the treatment of Kawasaki disease in children","author":"Oates-Whitehead","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0073|cit73","unstructured":"Ministry of Health and Welfare Japan Report of subcommittee on standardisation of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease Research Committee on Kawasaki Disease 1984"},{"key":"10.1002\/14651858.CD011188.pub3-BIB0074|cit74","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"11","key":"10.1002\/14651858.CD011188.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/archdischild-2014-307536","article-title":"The epidemiology of Kawasaki disease: a global update","volume":"100","author":"Singh","year":"2015","journal-title":"Archives of Disease in Childhood"},{"issue":"5","key":"10.1002\/14651858.CD011188.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","article-title":"Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance","volume":"158","author":"Sleeper","year":"2011","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD011188.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-3476(87)80246-9","article-title":"Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiographic study","volume":"111","author":"Tatara","year":"1987","journal-title":"Journal of Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD011188.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/hrt.2008.143669","article-title":"Kawasaki disease in children","volume":"95","author":"Wood","year":"2009","journal-title":"Heart"},{"issue":"3","key":"10.1002\/14651858.CD011188.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jmii.2017.08.012","article-title":"The prevention of coronary arterial abnormalities in Kawasaki disease: a meta-analysis of the corticosteroid effectiveness","volume":"51","author":"Yang","year":"2018","journal-title":"Journal of Microbiology, Immunology and Infection"},{"issue":"3","key":"10.1002\/14651858.CD011188.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00431-011-1585-4","article-title":"A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease","volume":"171","author":"Zhu","year":"2012","journal-title":"European Journal of Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD011188.pub3-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011188","article-title":"Corticosteroids for the treatment of Kawasaki disease in children","author":"Wardle","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011188.pub3-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011188.pub2","article-title":"Corticosteroids for the treatment of Kawasaki disease in children","author":"Wardle","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T20:08:37Z","timestamp":1727294917000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011188.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Vascular Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":82,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011188.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]}}}